You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

beta cells

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blasts 5 Percent or More of Bone Marrow Nucleated Cells,

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +10 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 17, 2021

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
Has Results
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021

A Long-term Follow-up Study in Subjects Who Received CTX001

Enrolling by invitation
  • Beta-Thalassemia
  • +6 more
  • CTX001
  • New York, New York
  • +12 more
Nov 18, 2022

Recurrent Anaplastic Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Classic Hodgkin Lymphoma Trial in

Recruiting
  • Recurrent Anaplastic Large Cell Lymphoma
  • +9 more
  • Anti-CD30/CD16A Monoclonal Antibody AFM13
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Beta-Thalassemia Trial in Worldwide (LentiGlobin BB305 Drug Product)

Active, not recruiting
  • Beta-Thalassemia
  • LentiGlobin BB305 Drug Product
  • Oakland, California
  • +8 more
Feb 4, 2022

Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage Trial in United States (radiation, drug,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Total-Body Irradiation
  • +8 more
  • Los Angeles, California
  • +9 more
Aug 19, 2022

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Recurrent DLBCL, Refractory DLBCL Trial in Sacramento (Chimeric Antigen Receptor T-Cell Therapy, Cyclophosphamide, Fludarabine

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Chimeric Antigen Receptor T-Cell Therapy
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Mar 8, 2022

Hematologic Diseases Trial in Kunming (BD211 Drug Product)

Enrolling by invitation
  • Hematologic Diseases
  • BD211 Drug Product
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force of People's Libe
Aug 14, 2021

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in Aurora,

Completed
  • Acute Biphenotypic Leukemia
  • +6 more
  • Aurora, Colorado
  • +2 more
Jan 12, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

ß-Thalassemia Major Trial in Shenzhen (ß-globin restored autologous HSC)

Not yet recruiting
  • β-Thalassemia Major
  • β-globin restored autologous HSC
  • Shenzhen, Guangdong, China
    Beijing Genomics Institute At Shenzhen
Oct 13, 2020

Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)

Terminated
Has Results
  • Burkitt Lymphoma
  • +6 more
  • Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 30, 2020

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Recruiting
  • Metastatic Melanoma
  • +5 more
  • Aldesleukin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 10, 2020

type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)

Recruiting
  • type1diabetes
  • +3 more
  • Parma, Pr, Italy
    Azienda Ospedaliero Universitaria di Parma
Dec 20, 2022

Type I Diabetes Trial in Birmingham (Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active

Completed
  • Type I Diabetes
  • Placebo GABA and Placebo GAD-alum
  • +2 more
  • Birmingham, Alabama
    Children's of Alabama
May 2, 2022

Role of TMEM219 Marker in Type 1 Diabetes

Recruiting
  • Diabetes Mellitus
    • Milan, Italy
      Pediatric Clinical Research Center
    May 16, 2022

    Type 1 Diabetes Trial in Nijmegen (68Ga-NODAGA-Exendin-4)

    Recruiting
    • Type 1 Diabetes
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Center
    Nov 17, 2022

    Squamous Cell Carcinoma of the Oral Cavity Trial in Taipei (ß-glucan)

    Unknown status
    • Squamous Cell Carcinoma of the Oral Cavity
    • β-glucan
    • Taipei, Taiwan
      National Taiwan University Hospital
    May 10, 2020

    Fabry Disease Trial in Seoul (Fabagal® (Agalsidase beta), Active comparator (Agalsidase beta))

    Recruiting
    • Fabry Disease
    • Fabagal® (Agalsidase beta)
    • Active comparator (Agalsidase beta)
    • Seoul, Songpa-gu, Korea, Republic of
      Seoul Asan Center
    Oct 10, 2023

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

    Terminated
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +9 more
    • Allogeneic Bone Marrow Transplantation
    • +7 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 4, 2021

    Diabetes Trial in Vienna, Paris (68Ga-NODAGA-exendin-4 PET/CT)

    Recruiting
    • Diabetes Mellitus
    • 68Ga-NODAGA-exendin-4 PET/CT
    • Vienna, Austria
    • +1 more
    Jun 16, 2022